RUNX1/CBFA2 Antibody

Product Specs
ItemRUNX1/CBFA2 Antibody - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $579.00Supplier Page View Company Product Page
Catalog NumberNBP1-89105
Quantity0.1 ml (also 25ul)
ApplicationsIF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Immunocytochemistry/ Immunofluorescence
Conjugate/TagUnconjugated
FormatPBS (pH 7.2) and 40% Glycerol
ReactivityHuman,Mouse
PurityAffinity purified
TargetRUNX1/CBFA2
HostRabbit
IsotypeIgG
Molecular Weight49 kDa
Antibody TypePrimary Antibodies
ImmunogenThis antibody was developed against Recombinant Protein corresponding to amino acids: PQPQSQMQDT RQIQPSPPWS YDQSYQYLGS IASPSVHPAT PISPGRASGM TTLSAELSSR LSTAPDLTAF SDPRQFPALP SISDPRMHYP GAFTYSPTPV TSGI
ClonalityPolyclonal
Research AreaCancer, Tumor Suppressors
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
NCBI Full Gene NameRUNX family transcription factor 1
NCBI Gene AliasesAML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1, PEBP2aB, PEBP2alpha

Specifications/Features

Available conjugates: Unconjugated

Sequence

PQPQSQMQDTRQIQPSPPWSYDQSYQYLGSIASPSVHPATPISPGRASGMTTLSAELSSRLSTAPDLTAFSDPRQFPALPSISDPRMHYPGAFTYSPTPVTSGI

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion proteinThe Journal of clinical investigationDecember 7, 2023Day RB, Hickman JA, Xu Z, Katerndahl CD, Ferraro F, Ramakrishnan SM, Erdmann-Gilmore P, Sprung RW, Mi Y, Townsend RR, et al.Slides were washed with PBS for 5 minutes, then incubated with primary antibody (RUNX1 antibody, Novus NBP1-89105; BirA/TurboID antibody, Novus NBP2-59939) overnight at 4°C in staining buffer (PBS, 1% BSA, 0.1% saponin).

(2) Divergent transcriptional regulation of astrocyte reactivity across disordersNatureJune 1, 2022Burda JE, O'Shea TM, Ao Y, Suresh KB, Wang S, Bernstein AM, Chandra A, Deverasetty S, Kawaguchi R, Kim JH, et al.Novus Biologicals); rabbit anti-Rpsa (1:200; NBP2–41246; Novus Biologicals); rabbit anti-Runx1 (1:200; NBP1–89105; Novus Biologicals); rabbit anti-Runx2 (1:200; A2851; Abclonal); rabbit anti-Runx3 (1:200; NBP2–38863;

(3) Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerPloS oneJanuary 1, 2014Ferrari N, Mohammed ZM, Nixon C, Mason SM, Mallon E, McMillan DC, Morris JS, Cameron ER, Edwards J, Blyth K.

Be the First to Write a Review!